Flawed invisible trial underpins US morning sickness drug, researchers say. | BMJ;356: j132, 2017 Jan 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Flawed invisible trial underpins US morning sickness drug, researchers say.

Dyer, Owen.

BMJ ; 356: j132, 2017 Jan 09.

Article in En | MEDLINE | ID: mdl-28069575

Subject(s)

Antiemetics/therapeutic use; Clinical Trials as Topic/standards; Dicyclomine/therapeutic use; Doxylamine/therapeutic use; Morning Sickness/drug therapy; Pyridoxine/therapeutic use; Drug Approval; Drug Combinations; Female; Humans; Pregnancy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridoxine / Clinical Trials as Topic / Morning Sickness / Dicyclomine / Doxylamine / Antiemetics Limits: Female / Humans / Pregnancy Language: En Journal: BMJ Journal subject: MEDICINA Year: 2017 Document type: Article Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridoxine / Clinical Trials as Topic / Morning Sickness / Dicyclomine / Doxylamine / Antiemetics Limits: Female / Humans / Pregnancy Language: En Journal: BMJ Journal subject: MEDICINA Year: 2017 Document type: Article Country of publication: United kingdom